Corpus Intelligence IC Memo — LEHIGH VALLEY HOSPITAL - SCHUYLKILL 2026-04-26 17:25 UTC
IC Memo — LEHIGH VALLEY HOSPITAL - SCHUYLKILL
Investment Committee Memorandum | PA | 118 beds | Grade C | EBITDA uplift $9.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

LEHIGH VALLEY HOSPITAL - SCHUYLKILL

CCN 390030 | SCHUYLKILL, PA | 118 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

LEHIGH VALLEY HOSPITAL - SCHUYLKILL is a 118-bed suburban community hospital in SCHUYLKILL, PA with $134.8M in net patient revenue and a -2.3% operating margin. The hospital serves a payer mix of 27.7% Medicare, 6.8% Medicaid, and 65.5% commercial.

Thesis: Undervalued. Our ML models identify $9.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -2.3% to 5.0% (+736bps).

Net Revenue HCRIS$134.8M
Current EBITDA COMPUTED$-3.1M
Operating Margin COMPUTED-2.3%
Occupancy HCRIS53.6%
Revenue / Bed COMPUTED$1.1M
Net-to-Gross HCRIS22.8%
Distress Probability ML47.3%

2. Market Context & Competitive Position

225
PA Hospitals
-4.4%
State Median Margin
103
Comparable Hospitals

PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of -2.3% places it above the state median. Among 103 size-comparable peers (59-236 beds), the median margin is -6.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (59-236), prioritizing same-state peers. 103 hospitals in the comp set.

HospitalStateBedsRevenueMargin
LEHIGH VALLEY HOSPITAL - SCHUY (Target)PA118$134.8M-2.3%
WILLIAMSPORT HOSPITAL & MEDICAPA227$459.8M-8.4%
THE CHAMBERSBURG HOSPITALPA234$435.1M5.2%
ST LUKE HOSPITAL ANDERSON CAMPPA193$433.0M20.6%
THE GETTYSBURG HOSPITALPA76$341.8M18.4%
ST. JOSEPH MEDICAL CENTERPA132$334.8M13.2%
FORBES REGIONAL HOSPITALPA233$327.4M-3.8%
HOLY SPIRIT HOSPITALPA231$295.1M-1.0%
EPHRATA COMMUNITY HOSPITALPA115$291.8M3.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.8M+210bp18mo
Cost to Collect4.5%2.5%$2.7M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.6M+122bp9mo
Clean Claim Rate88.0%96.0%$86K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.8M
Cost to Collect
$2.7M
Denial Rate Reduction
$2.7M
A/R Days Reduction
$1.6M
Clean Claim Rate
$86K
Total EBITDA Uplift$9.9M
Current EBITDA$-3.1M
+ RCM Uplift+$9.9M
Pro Forma EBITDA$6.8M
Current Margin-2.3%
Pro Forma Margin5.0%
WC Released (1x)$5.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-4.8M$78.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-4.8M$84.9M0.00x-100.0%
Bull Case9.0x11.0x$-4.3M$116.1M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-4.3M$125.3M0.00x-100.0%
Bear Case11.0x10.0x$-5.3M$30.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-5.3M$31.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 103 hospitals with 59-236 beds
  • Same-state prioritization (n=104)
  • Comp margins: P25=-18.9% / P50=-6.5% / P75=7.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.